Back
Protagonist Therapeutics Vs. JD.com Industry Stock Comparison
Sell
47
PTGX
Protagonist Therapeutics
Last Price:
44.54
Seasonality Move:
15.58%
Buy
85
JD
JD.com
Last Price:
39.91
Seasonality Move:
2.36%
Sell
47
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $44.93. The Score for PTGX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
85
JD.com (JD)
is a Buy
Is JD.com a Buy, Sell or Hold?
- The current JD.com [JD] share price is $37.99. The Score for JD is 85, which is 70% above its historic median score of 50, and infers lower risk than normal.
- JD is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $44.93
The current trend is moderately bearish and PTGX is experiencing selling pressure, which indicates risk of future bearish movement.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.43 | Buy |
| Relative Strength Index (14 RSI): | 54.71 | Buy |
| Chaikin Money Flow: | -385158 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (42.06 - 46.06) | Buy |
| Bollinger Bands (100): | (31.14 - 42.38) | Buy |
JD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.85 | Buy |
| Relative Strength Index (14 RSI): | 83.58 | Buy |
| Chaikin Money Flow: | 36035340 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.86 - 30.7) | Buy |
| Bollinger Bands (100): | (25.63 - 31.13) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 45.84 | Sell |
| 20-day SMA: | 44.59 | Buy |
| 50-day SMA: | 41.44 | Buy |
| 200-day SMA: | 31.51 | Buy |
| 8-day EMA: | 45.74 | Sell |
| 20-day EMA: | 44.65 | Buy |
| 50-day EMA: | 41.66 | Buy |
| 200-day EMA: | 32.9 | Buy |
JD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.75 | Buy |
| 20-day SMA: | 28.15 | Buy |
| 50-day SMA: | 27.11 | Buy |
| 200-day SMA: | 26.99 | Buy |
| 8-day EMA: | 31.87 | Buy |
| 20-day EMA: | 29.26 | Buy |
| 50-day EMA: | 27.97 | Buy |
| 200-day EMA: | 28.53 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, an increase next quarter of $0.26 per share, an increase this year of $4.50 per share, and a decrease next year of $2.97 per share.
JD.com Earnings Growth & JD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.24 per share, an increase next quarter of $0.25 per share, an increase this year of $1.01 per share, and an increase next year of $0.23 per share.
Protagonist Therapeutics Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
JD.com Technical Analysis
| Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||